These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 4270935

  • 1. Studies on bone marrow transplantation in experimental 32P-induced aplastic anemia after conditioning with antilymphocyte serum.
    Speck B, Kissling M.
    Acta Haematol; 1973 Oct; 50(4):193-9. PubMed ID: 4270935
    [No Abstract] [Full Text] [Related]

  • 2. Progress in the prevention of GVH: bone marrow grafts after ALG conditioning, with lymphocyte split chimerism, use of a lymphocyte "chalone T", and soluble histocompatibility antigens.
    Mathé G, Kiger N, Florentin I, Garcia-Giralt E, Martyre MC, Halle-Pannenko O, Schwartzenberg L.
    Transplant Proc; 1973 Mar; 5(1):933-9. PubMed ID: 4144474
    [No Abstract] [Full Text] [Related]

  • 3. Bone marrow transplantation after antilymphocyte globulin conditioning--split lymphocyte chimerism.
    Mathé G, Schwarzenberg L, Amiel JL, Schneider M, Belpomme D, Jasmin C, Rosenfeld C, Hayat M, de Vassal F, Steresco M.
    Transplant Proc; 1972 Dec; 4(4):551-7. PubMed ID: 4566797
    [No Abstract] [Full Text] [Related]

  • 4. Allogeneic marrow transplantation using matched sibling donors.
    Thomas ED.
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):115-9. PubMed ID: 4155158
    [No Abstract] [Full Text] [Related]

  • 5. Successful bone marrow grafts in experimental aplastic anemia using antilymphocytic serum for conditioning.
    Speck B, Kissling M.
    Rev Eur Etud Clin Biol; 1971 Dec; 16(10):1047-51. PubMed ID: 4400852
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cell-mediated immunity and serum blocking factor in tolerance produced in mice with antilymphocyte serum and bone marrow cell infusion.
    Wood ML, Gozzo JJ, Heppner G, Monaco AP.
    Transplant Proc; 1972 Sep; 4(3):383-9. PubMed ID: 4263511
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Rationale for the use of ALG as sole immunosuppressant in allogeneic bone marrow transplantation for aplastic anemia.
    Speck B, Buckner CD, Cornu P, Jeannet B.
    Transplant Proc; 1976 Dec; 8(4):617-22. PubMed ID: 11593
    [No Abstract] [Full Text] [Related]

  • 11. Beneficial influence of limited histocompatibility of bone marrow grafted to unrelated rhesus monkeys preconditioned with x-ray and ALS.
    Neffe JR, Merritt CB, Darrow CC, Rogentine GN.
    Transplant Proc; 1974 Jun; 6(2):125-8. PubMed ID: 4208750
    [No Abstract] [Full Text] [Related]

  • 12. Bone marrow transplantation: introduction.
    Mathé G, Oldham R.
    Transplant Proc; 1974 Dec; 6(4):333-4. PubMed ID: 4155149
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Immunosuppression of the donor in order to affect chronic secondary disease of the recipient.
    Thierfelder S, Werner J, Götze D.
    Blut; 1970 Dec; 21(6):384-8. PubMed ID: 4923980
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.